Neural substrates underlying REM sleep duration in patients with major depressive disorder: A longitudinal study

Cun Zhang1, Dao-Min Zhu2, Yu Zhang2

  • 1Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; Research Center of Clinical Medical Imaging, Anhui Province, Hefei 230032, China; Anhui Provincial Institute of Translational Medicine, Hefei 230032, China.

PubMed
Abstract

Insights

Major depressive disorder (MDD) patients show altered brain activity linked to rapid eye movement (REM) sleep duration (REM%). This REM% may serve as a prognostic biomarker for predicting depression symptom improvement.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Sleep Medicine

Background:

  • Rapid eye movement (REM) sleep disturbance is a potential endophenotype of major depressive disorder (MDD).
  • The neural mechanisms connecting REM sleep duration (REM%) and MDD progression are not fully understood.

Purpose of the Study:

  • To investigate the neural substrates of REM% in MDD patients.
  • To explore the association between baseline REM% and brain imaging metrics.
  • To determine if REM% can predict depressive symptom improvement in MDD.

Main Methods:

  • Resting-state functional and perfusion MRI and polysomnography were used in 114 MDD patients and 74 healthy controls.
  • Correlation and mediation analyses examined relationships between REM%, brain imaging, and symptom improvement at follow-up.

Main Results:

  • Significant correlations were found between REM% and brain imaging metrics in regions related to sensorimotor, visual, emotional, and cognitive processing in MDD patients.
  • Baseline REM% correlated with symptom improvement, mediated by changes in left inferior temporal gyrus activity and bilateral paracentral lobule cerebral blood flow.

Conclusions:

  • REM% is associated with specific neural underpinnings in MDD.
  • REM% shows potential as a prognostic biomarker for predicting disease progression and treatment response in MDD.
  • Targeting REM sleep may offer novel therapeutic strategies for MDD.

Related Concept Videos

REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
211
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.4K
Stages of Sleep01:22

Stages of Sleep

Sleep progresses through distinct stages, each characterized by specific brain wave patterns and physiological responses ranging from wakefulness to stages of non-rapid eye movement, known as non-REM, to rapid eye movement, referred to as REM. Understanding these stages helps in recognizing how sleep supports various bodily and cognitive functions.
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
201